Benelux Cancer Therapeutics Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
No. of Pages: 150 | Report Code: BMIRE00031441 | Category: Life Sciences
No. of Pages: 150 | Report Code: BMIRE00031441 | Category: Life Sciences
The cancer therapeutics market size is expected to reach US$ 9,046.99 million by 2031 from US$ 4,396.94 million in 2024. The market is estimated to record a CAGR of 10.53% from 2025 to 2031.
Governments in the Benelux countries, alongside the European Union, provide substantial funding for cancer research and drug development. Initiatives such as Horizon Europe help foster innovation, enabling the rapid development and availability of novel cancer therapies.
Moreover, the Benelux region is home to a thriving pharmaceutical and biotech industry, with major global companies having a significant presence. Companies such as Johnson & Johnson, Acerta Pharma, and OncoDNA are actively involved in cancer drug development and clinical trials, further boosting the availability of novel cancer therapeutics in the region.
Key segments that contributed to the derivation of the cancer therapeutics market analysis are therapy type, indication, and distribution channel.
According to the Spanish Network of Cancer Registries, ~11,734 breast cancer cases were diagnosed in November 2022 in Belgium. Breast cancer was responsible for 2,362 deaths in the country in the said year. The increasing cancer incidence heightens the demand for cancer therapeutics in the country.
Additionally, there has been a significant increase in research and development for more effective and personalized cancer treatments. The Benelux region is known for its high level of investment in healthcare and biotechnology research. In Netherlands, Cancer therapeutics is a dynamic and rapidly evolving sector, driven by advancements in research, technology, and a robust healthcare system. The Dutch Cancer Society funds research and supports initiatives aimed at improving cancer care and outcomes. In September 2024, the Dutch Research Council (NWO) provided US$ 27.8 million (25 million euros) to address the ever-increasing challenges in cancer patient care. The number of cancer patients was expected to rise from 800,000 in 2022 to 1.4 million in 2031.
Based on region, the Benelux cancer therapeutics market is further segmented into the Belgium, the Netherlands, and Luxembourg. The Belgium held the largest share in 2024.
Belgium is home to numerous research collaborations, particularly in to fight against cancer. In April 2023, DeuterOncology, a Liège-based biotech company, was successfully awarded the Win4Company grant by Service Public de Wallonie (SPW) Recherche. This clinical-stage drug development company received US$ 0.53 million (0.47 million EUR) to establish a partnership with Radiomics, another Liège-based biotech, to combine their expertise in order to improve cancer therapy through the development and validation of an AI-based imaging biomarker as a potential companion diagnostic for a novel best-in-class deuterated MET kinase inhibitor (DO-2). The development of such novel biomarkers would allow the company to optimize and personalized cancer therapies. The grant brought together the expertise of two Belgian biotech companies for identifying subsets of lung cancer patients with MET gene alterations.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 4,396.94 Million |
| Market Size by 2031 | US$ 9,046.99 Million |
| Global CAGR (2025 - 2031) | 10.53% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Therapy Type
|
| Regions and Countries Covered | Benelux
|
| Market leaders and key company profiles |
Johnson & Johnson; AstraZeneca; GlaxoSmithKline BV; Modra Pharmaceuticals B.V; Telix Pharmaceuticals Limited; Sirius Medical; Gilead Sciences; LIXTE Biotechnology Holdings, Inc; Serb Pharmaceuticals; and iTeos Therapeutics are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The Benelux Cancer Therapeutics Market is valued at US$ 4,396.94 Million in 2024, it is projected to reach US$ 9,046.99 Million by 2031.
As per our report Benelux Cancer Therapeutics Market, the market size is valued at US$ 4,396.94 Million in 2024, projecting it to reach US$ 9,046.99 Million by 2031. This translates to a CAGR of approximately 10.53% during the forecast period.
The Benelux Cancer Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Benelux Cancer Therapeutics Market report:
The Benelux Cancer Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Benelux Cancer Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Benelux Cancer Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Benelux Cancer Therapeutics Market
